【Bora】Subsidiary Bora Pharmaceuticals Inc. Announces Signing of Long-Term Manufacturing Agreement

1. Date of Occurrence: 115/05/18 2. Counterparty to the contract or commitment: Counterparty (undisclosed due to confidentiality agreement) 3. Relationship with the Company: Non-related party 4. Start and end date of the contract or commitment: Effective from the signing date for a term of 10 years, with an automatic renewal for 2 years upon expiration 5. Main content: To provide various support services including but not limited to development, manufacturing, packaging, and analysis during the contract period. 6. Restrictive covenants: As per the contract 7. Commitments: Compliance and cooperation with ESG regulations, with other terms as per the contract 8. Other important agreements: As per the contract 9. Impact on company's finance and business: Positive effect on the company's future revenue and operational scale 10. Specific purpose: To strengthen Bora's positioning as a long-term CDMO strategic partner for international pharmaceutical companies, continuously expand the CDMO business, and actively enter the field of new drug and biologics manufacturing 11. Other relevant information: The counterparty is a top 20 global pharmaceutical company.